======= SRA1 ======= == Gene Information == * **Official Symbol**: SRA1 * **Official Name**: steroid receptor RNA activator 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10011|10011]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9HD15|Q9HD15]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SRA1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SRA1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603819|Open OMIM]] == Function Summary == * **Entrez Summary**: Both long non-coding and protein-coding RNAs are transcribed from this gene, and they represent alternatively spliced transcript variants. This gene was initially defined as a non-coding RNA, which is a coactivator for several nuclear receptors (NRs) and is associated with breast cancer. It has now been found that this gene is involved in the regulation of many NR and non-NR activities, including metabolism, adipogenesis and chromatin organization. The long non-coding RNA transcripts interact with a variety of proteins, including the protein encoded by this gene. The encoded protein acts as a transcriptional repressor by binding to the non-coding RNA. [provided by RefSeq, Mar 2012]. * **UniProt Summary**: Functional RNA which acts as a transcriptional coactivator that selectively enhances steroid receptor-mediated transactivation ligand-independently through a mechanism involving the modulating N-terminal domain (AF-1) of steroid receptors. Also mediates transcriptional coactivation of steroid receptors ligand- dependently through the steroid-binding domain (AF-2). Enhances cellular proliferation and differentiation and promotes apoptosis in vivo. May play a role in tumorigenesis. {ECO:0000269|PubMed:10199399, ECO:0000269|PubMed:12943696, ECO:0000269|PubMed:14517287, ECO:0000269|PubMed:15147866, ECO:0000269|PubMed:15351741}. |SRA1| |steroid receptor RNA activator RNA binding| |cellular response to estrogen stimulus| |negative regulation of myoblast differentiation| |cell leading edge| |regulation of myoblast differentiation| |intercellular bridge| |nuclear receptor transcription coactivator activity| |response to estrogen| |microtubule cytoskeleton| |ribonucleoprotein complex| |transcription factor complex| |transcription coactivator activity| |cell population proliferation| |negative regulation of cell differentiation| |apoptotic process| |negative regulation of developmental process| |programmed cell death| |cell death| |DNA binding| |regulation of apoptotic process| |regulation of programmed cell death| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of cell death| |positive regulation of RNA metabolic process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp116|AICAR 240μM R03 exp116]]|-2.03| |[[:results:exp165|RO-3306 3 to 4μM on day4 R04 exp165]]|-1.72| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18592 * **Expression level (log2 read counts)**: 3.24 {{:chemogenomics:nalm6 dist.png?nolink |}}